MGTX
MeiraGTx Holdings plc

938
Mkt Cap
$701.5M
Volume
407,693.00
52W High
$9.44
52W Low
$4.55
PE Ratio
-4.28
MGTX Fundamentals
Price
$8.72
Prev Close
$8.75
Open
$8.89
50D MA
$7.95
Beta
1.18
Avg. Volume
340,816.52
EPS (Annual)
-$2.12
P/B
237.02
Rev/Employee
$87,346.46
Loading...
Loading...
News
all
press releases
MeiraGTx (MGTX) Moves 12.4% Higher: Will This Strength Last?
MeiraGTx (MGTX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Zacks·4d ago
News Placeholder
More News
News Placeholder
MeiraGTx Holdings PLC (MGTX) Reports Q2 Loss, Beats Revenue Estimates
MeiraGTx (MGTX) delivered earnings and revenue surprises of +7.69% and +59.78%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
Xilio Therapeutics, Inc. (XLO) Reports Q2 Loss, Misses Revenue Estimates
Xilio Therapeutics (XLO) delivered earnings and revenue surprises of -100.00% and -10.38%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
InflaRx N.V. (IFRX) Reports Q2 Loss, Misses Revenue Estimates
InflaRx (IFRX) delivered earnings and revenue surprises of 0.00% and -61.21%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3mo ago
News Placeholder
3 Promising Genomics Stocks to Keep an Eye On in 2025
Investors interested in the Genomics and Synthetic Biology theme should keep an eye on MGTX, BEAM and KRYS.
Zacks·4mo ago
News Placeholder
MeiraGTx Holdings PLC (MGTX) Reports Q1 Loss, Misses Revenue Estimates
Zacks·6mo ago
News Placeholder
Ascentage Pharma Appoints Ms. Marina S. Bozilenko and Dr. Debra Yu as Independent Non-Executive Directors
Ascentage Pharma Appoints Ms. Marina S. Bozilenko and Dr. Debra Yu as Independent Non-Executive Directors Ascentage Pharma Appoints Ms. Marina S. Bozilenko and Dr. Debra Yu as Independent...
PR Newswire·11mo ago
News Placeholder
MeiraGTx Holdings (MGTX, $5.82) Stochastic Oscillator left the oversold zone on April 01, 2024
This is a signal that MGTX's price trend could be reversing, and it may be an opportunity to buy the stock or explore call options...
Tickeron - Stocks·2y ago
News Placeholder
MeiraGTx Holdings plc (MGTX, $6.07) entered Uptrend as Momentum indicator ascends above 0 level on Mar 28, 2024
This indicator may be signaling MGTX's price has momentum to move higher, since its current price moved above its price 14 days ago. Traders may consider buying the stock or exploring call options...
Tickeron - Stocks·2y ago
News Placeholder
MeiraGTx Holdings (MGTX, $6.07) Moving Average Convergence Divergence (MACD) Histogram turned negative on March 28, 2024
This is a Bearish indicator signaling MGTX's price could decline from here. Traders may explore shorting the stock or put options...
Tickeron - Stocks·2y ago

Latest MGTX News

View

Advertisement|Remove ads.

Advertisement|Remove ads.